Drug intelligence / Profile preview

perindopril

Development stage
Approved
Lead developer
Servier
Modality
Small Molecules
Administration
Oral
01

Overview

Perindopril is a long-acting angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension), heart failure, and stable coronary artery disease. It works by inhibiting the conversion of angiotensin I to angiotensin II, a hormone that causes blood vessels to constrict. By blocking this process, perindopril relaxes blood vessels, lowers blood pressure, increases urine output and sodium excretion, and reduces the workload on the heart. Perindopril is administered orally as a prodrug and is converted in the liver to its active metabolite, perindoprilat. The drug was patented in 1980 and approved for medical use in 1988[5][6][7][8].

Brand names
Aceon
Other names
perindopril erbumineperindopril arginineperindoprilat
02

Targets

ACE C-domain (Angiotensin-converting enzyme C-domain)

Beyond the preview

Go deeper on perindopril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perindopril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call